US regulators have finalized a new set of recommendations intended to make infusion pumps safer and more reliable. In the US, medical devices can come to market in a variety of different ways. Some ...

A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...

Hospira ($HSP) now faces a Class I recall--the FDA's most serious--because of malfunctioning problems with the company's Symbiq infusion pump system. The designation ...

The U.S. Food and Drug Administration (FDA) issued a warning letter to Hospira, Inc., about problems with alarm systems in its infusion pumps, according to a Reuters report. Hospira said the letter ...

Infusion centers are caught between two forces that won’t relent: patient volumes that keep climbing and clinician pipelines that can’t keep pace. For many organizations, the instinct is to hire more ...